Back to calendar
Supernus Pharmaceuticals, Inc. (SUPN) Earnings
SUPN reports earnings on Tuesday, August 11, 2026
earnings report
August 11, 2026 · Before Market Open
Q2 2026
Est. EPS: $0.43
Actual EPS: $0.60
EPS surprise: 102.30%
Company overview
Market Cap$2.8B
PriceUSD 47.73
EPS (TTM)-0.51
52-week high59.68
52-week low32.20
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees778